Safety of BTZ retreatment for patients with low-grade peripheral neuropathy during the initial treatment.
Vidisheva, Aleksandra P
Safety of BTZ retreatment for patients with low-grade peripheral neuropathy during the initial treatment. [electronic resource] - Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 10 2017 - 3217-3224 p. digital
Publication Type: Journal Article
1433-7339
10.1007/s00520-017-3732-6 doi
Adult
Aged
Aged, 80 and over
Antineoplastic Agents--administration & dosage
Bortezomib--administration & dosage
Female
Humans
Incidence
Male
Middle Aged
Multiple Myeloma--complications
Peripheral Nervous System Diseases--drug therapy
Recurrence
Retreatment
Retrospective Studies
Risk Factors
Severity of Illness Index
Treatment Outcome
Safety of BTZ retreatment for patients with low-grade peripheral neuropathy during the initial treatment. [electronic resource] - Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 10 2017 - 3217-3224 p. digital
Publication Type: Journal Article
1433-7339
10.1007/s00520-017-3732-6 doi
Adult
Aged
Aged, 80 and over
Antineoplastic Agents--administration & dosage
Bortezomib--administration & dosage
Female
Humans
Incidence
Male
Middle Aged
Multiple Myeloma--complications
Peripheral Nervous System Diseases--drug therapy
Recurrence
Retreatment
Retrospective Studies
Risk Factors
Severity of Illness Index
Treatment Outcome